PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical Assays.

Am J Surg Pathol 2021 Jun 10

PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical Assays.

Related Questions

What neoadjuvant chemotherapy will you give to a premenopausal woman with cT2N0 metaplastic triple negative breast cancer?

New comment by Medical Oncologist at NYU Winthrop Hospital ( October 31, 2021)

AC-T with Pembrolizumab.

Read more (3 Answers available)